Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Peretz, Weiss"'
Autor:
Yelena Lapidot, Amnon Amir, Rita Nosenko, Atara Uzan-Yulzari, Ella Veitsman, Oranit Cohen-Ezra, Yana Davidov, Peretz Weiss, Tanya Bradichevski, Shlomo Segev, Omry Koren, Michal Safran, Ziv Ben-Ari
Publikováno v:
mSystems, Vol 5, Iss 3 (2020)
ABSTRACT Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related mortality worldwide. While cirrhosis is the main risk factor for HCC, the factors influencing progression from cirrhosis to HCC remain largely unknown. Gut microbio
Externí odkaz:
https://doaj.org/article/5538f047e5454237be383740824594a1
Publikováno v:
Data in Brief, Vol 14, Iss C, Pp 777-781 (2017)
This article provides a protocol for determination of human procollagen C-proteinase enhancer 1 (PCPE-1) concentrations by ELISA. The inter-assay and intra-assay coefficients of variability are given and so are the average plasma concentrations of PC
Externí odkaz:
https://doaj.org/article/0bd3ae0446394e60b76b02578a830a46
Autor:
Ziv Ben-Ari, David Levingston, Ella Weitzman, Yael Haviv-Yadid, Oranit Cohen-Ezra, Peretz Weiss, Eli Zuckerman, Yael Inbar, Michal Amitai, Uri Rimon, Maya Goder, Josef Haik
Publikováno v:
Annals of Hepatology, Vol 14, Iss 5, Pp 695-701 (2015)
Background and aims. Secondary sclerosing cholangitis in critically ill patients (SSC-CIP) is a relatively new previously unrecognized entity which may lead to severe biliary disease with rapid progression to cirrhosis. We present for the first time
Externí odkaz:
https://doaj.org/article/ea7ba4b61dd343e88670109dfba0f559
Autor:
Shlomo Segev, Amnon Amir, Omry Koren, T. Bradichevski, Yana Davidov, Ella Veitsman, Ziv Ben-Ari, Michal Safran, Yelena Lapidot, Shira Ben-Simon, Oranit Cohen-Ezra, Peretz Weiss
Publikováno v:
Hepatology International. 15:191-201
Primary sclerosing cholangitis (PSC) is a chronic, progressive liver disease known for its frequent concurrence with inflammatory bowel disease. PSC can progress to cirrhosis, end-stage liver disease, hepatobiliary cancer, and/or colorectal cancer. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::07cc2eb055e37ae71fc5409bd36a9586
https://doi.org/10.1007/s12072-020-10089-z
https://doi.org/10.1007/s12072-020-10089-z
Autor:
Yana, Davidov, Yeruham, Kleinbaum, Yael, Inbar, Oranit, Cohen-Ezra, Ella, Veitsman, Peretz, Weiss, Mariya, Likhter, Tania, Berdichevski, Sima, Katsherginsky, Avishag, Hassid, Keren, Tsaraf, Dana, Silverberg, Ziv, Ben Ari
Publikováno v:
The Israel Medical Association journal : IMAJ. 23(12)
New direct acting antiviral agent (DAA) therapies are associated with a high sustained virological response rate (SVR) in hepatitis C virus (HCV) patients. The understanding of the impact of SVR on fibrosis stage is limited.To determine the effect of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::88f009fa607ec0e6f3b7964cd5f4d501
https://pubmed.ncbi.nlm.nih.gov/34954919
https://pubmed.ncbi.nlm.nih.gov/34954919
Autor:
Amnon Amir, Tanya Bradichevski, Ella Veitsman, Ziv Ben-Ari, Yelena Lapidot, Yana Davidov, Shlomo Segev, Michal Safran, Oranit Cohen-Ezra, Rita Nosenko, Atara Uzan-Yulzari, Peretz Weiss, Omry Koren
Publikováno v:
mSystems, Vol 5, Iss 3 (2020)
mSystems, Vol 5, Iss 3, p e00153-20 (2020)
mSystems
mSystems, Vol 5, Iss 3, p e00153-20 (2020)
mSystems
Development of hepatocellular carcinoma in patients with cirrhosis is associated with alterations in intestinal microbiota, including an escalation of dysbiosis and reduced bacterial richness. This study demonstrates that reduced bacterial richness a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a8185d778f8cfd75d88fbd4ca53c1c7
https://doi.org/10.1128/msystems.00153-20
https://doi.org/10.1128/msystems.00153-20
Autor:
Omry Koren, Michal Safran, Ella Veitsman, Mariya Likhter, Yelena Lapidot, Shira Ben-Simon, Peretz Weiss, Ziv Ben Ari, Oranit Cohen-Ezra, Yana Davidov
Publikováno v:
Journal of Hepatology. 70:e516-e517
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::71406458f09f5f2cb9d12b0c2507431e
https://doi.org/10.1016/s0618-8278(19)31020-5
https://doi.org/10.1016/s0618-8278(19)31020-5
Autor:
Eyal, Lotan, Stephen P, Raskin, Michal M, Amitai, Yeruham, Kleinbaum, Ella, Veitsman, Peretz, Weiss, Oranit, Cohen-Ezra, Tania, Berdichevski, Ziv, Ben-Ari
Publikováno v:
The Israel Medical Association journal : IMAJ. 19(4)
Accurate assessment of liver fibrosis is crucial for the management of patients with hepatitis C virus (HCV) infection.To evaluate the performance of liver segment-to-spleen volume ratio in predicting the severity of liver fibrosis.Sixty-four consecu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bd151bbb6285da4d68a51312d985462f
https://pubmed.ncbi.nlm.nih.gov/28480681
https://pubmed.ncbi.nlm.nih.gov/28480681
Autor:
Yael Gozlan, Ziv Ben-Ari, Roy Moscona, Rachel Shirazi, Aviya Rakovsky, Arij Kabat, Ella Veizman, Tania Berdichevski, Peretz Weiss, Oranit Cohen-Ezra, Yoav Lurie, Inna Gafanovich, Marius Braun, Michal Cohen-Naftaly, Amir Shlomai, Oren Shibolet, Ehud Zigmond, Eli Zuckerman, Michal Carmiel-Haggai, Assy Nimer, Rawi Hazzan, Yaakov Maor, Yona Kitay-Cohen, Yonat Shemer-Avni, Zipi Kra-Oz, Licita Schreiber, Ofer Peleg, Saleta Sierra, P Richard Harrigan, Ella Mendelson, Orna Mor
Publikováno v:
Antiviral therapy. 22(5)
Background Direct-acting antiviral (DAA) treatment regimens and response rates of patients with HCV genotype-1 (GT1) are currently considered subtype-dependent. Identification of clinically relevant resistance-associated substitutions (RASs) in the N
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38d536e11562b33910048f132645556a
https://pubmed.ncbi.nlm.nih.gov/28067632
https://pubmed.ncbi.nlm.nih.gov/28067632
Autor:
T. Engel, R. Nosenko, Michal Safran, Ziv Ben Ari, Omry Koren, Oranit Cohen-Ezra, V. Ella, I. Kalisky, B. Gayshis, Mariya Likhter, Yana Davidov, D. Ben-Ami, R. Margalit, Yelena Lapidot, Peretz Weiss
Publikováno v:
Journal of Hepatology. 68:S608-S609
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29ca557e491151ffe827b3565ce60238
https://doi.org/10.1016/s0168-8278(18)31471-5
https://doi.org/10.1016/s0168-8278(18)31471-5